Active Grants

Below is a list of the “active” grants of the Flinn Foundation—those grants that have been awarded and have yet to receive final payment; and/or for which grant-related activities have not concluded.

Many Flinn Foundation grants are multi-year awards that receive payments at several junctures. In some cases, grants are extended (without additional funding) beyond their scheduled date of conclusion.

This list is not comprehensive, as it excludes modest grants for membership dues to philanthropic organizations and other miscellaneous awards, but represents the Foundation’s project-specific grant-making activity to achieve its strategic goals.

Arizona Bioindustry Association

City: Phoenix

Amount: $239,750

Award Date: 2022

Duration: 12 months

Program Area: Bioscience

Partnership with seven 2022 awardees of funding and program services through the Flinn Foundation Bioscience Entrepreneurship Program:
 

Anuncia Medical   

Anuncia Medical of Scottsdale is the developer of the ReFlow™ Ventricular System, which helps patients with cerebrospinal fluid disorders, such as hydrocephalus, a debilitating and life-threatening condition affecting more than 1 million U.S. patients. The device, which is placed beneath the scalp, facilitates a safe, noninvasive retrograde fluid flush when ventriculoperitoneal shunt flow is restricted or blocked.

Beacon Biomedical   

Beacon Biomedical provides easy, accurate, and affordable blood tests for earlier cancer detection as well as COVID-19 virus detection and antibodies testing. The company’s lead product, BeScreened™-CRC, is a blood-based test for the early detection of colorectal cancer. The Phoenix-based company also has early detection assays for breast, lung, prostate, and ovarian cancers in development.

Navi Nurses   

Phoenix-based Navi Nurses offers personalized, private nursing care after surgery and hospitalization. Navi Nurses exclusively hires bachelor-degree-and-higher registered nurses and provides carefully matched care based on the needs of the individual in the homecare setting.

NeuTherapeutics   

NeuTherapeutics is a Tucson-based company whose mission is to provide safe and effective regenerative treatments for the brain to cure neurodegenerative diseases and precision therapies that preserve women’s brain health. The company’s lead molecule, Allopregnanolone, is a clinical-stage, regenerative treatment for Alzheimer’s disease and other neurodegenerative diseases that generates new neurons, new synapses, and new neural circuits in the Alzheimer’s brain.

ReSuture   

ReSuture has created a synthetic vasculature that mimics the properties of live human tissue for surgical training, delivering a lifelike procedural experience to allow surgeons to gain operative experience in a controlled environment. The Surprise-based company seeks to reduce surgical complications and improve patient outcomes by giving future surgeons a superior training experience.

SaiOx   

Tucson-based SaiOx Inc. has developed Hespiro™, a respiratory-assist device that helps treat chronic obstructive pulmonary disorder, or COPD, and other respiratory diseases. The system, which improves patient comfort and reduces intubation occurrences, delivers a mixture of helium and oxygen, and captures exhaled gas and scrubs it free of carbon dioxide in a completely closed “rebreather” system.

uPetsia   

uPetsia solves the problem of bad dog breath by modifying natural canine oral bacteria. The bacteria can be incorporated into dog treats and chews, giving them fresh breath with a mint aroma for several hours. The Tucson-based firm was one of five companies that won Purina’s 2022 Pet Care Innovation Prize.

Arizona Center for Nature Conservation (Phoenix Zoo)

City: Phoenix

Amount: $80,000

Award Date: 2022

Duration: 24 months

Program Area: Arts and Culture

Support for a project advancing organizational goals in the “post-pandemic” period. This grant, awarded under the Foundation’s arts-and-culture Initiative for Financial and Creative Health, will involve close examination of the organization’s capitalization strategies.

Arizona Commission on the Arts

City: Phoenix

Amount: $20,000

Award Date: 2021

Duration: 36 months

Program Area: Arts and Culture

Support for the Commission’s SMU DataArts liaison position, which provides localized technical support to Arizona organization users of the DataArts system, continuing a collaboration among the Commission, the Virginia G. Piper Charitable Trust, and the Flinn Foundation to work with DataArts on behalf of Arizona’s arts-and-culture sector.

Arizona Opera

City: Phoenix

Amount: $80,000

Award Date: 2022

Duration: 24 months

Program Area: Arts and Culture

Support for a project advancing organizational goals in the “post-pandemic” period. This grant, awarded under the Foundation’s arts-and-culture Initiative for Financial and Creative Health, will involve close examination of the organization’s capitalization strategies.

Arizona Republic

City: Phoenix

Amount: $300,000

Award Date: 2019

Duration: 24 months

Program Area: Bioscience

Expenditure-responsibility grant to support a multimedia journalism initiative to deepen public understanding of bioscience research, industry development, and clinical advances in Arizona. This grant supports two new positions at the Republic: a multimedia reporter and a digital developer; while the reporter publishes articles, video reports, and other content for the Republic’s audiences, the developer will incorporate the content in cutting-edge formats, including virtual and augmented reality. Although these new-media projects will be available globally on multiple platforms, the developer will particularly concentrate on preparing them to be showcased at in-person events connecting the public to the biosciences.